Correlation Between Cullinan Oncology and Dice Molecules

Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Dice Molecules at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Dice Molecules into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cullinan Oncology LLC and Dice Molecules Holdings, you can compare the effects of market volatilities on Cullinan Oncology and Dice Molecules and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Dice Molecules. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Dice Molecules.

Diversification Opportunities for Cullinan Oncology and Dice Molecules

0.62

Correlation Coefficient

Cullinan Oncology  Dice Molecules

Poor diversification

The 3 months correlation between Cullinan and Dice is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Dice Molecules Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dice Molecules Holdings and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Dice Molecules. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dice Molecules Holdings has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Dice Molecules go up and down completely randomly.

Pair Corralation between Cullinan Oncology and Dice Molecules

Given the investment horizon of 90 days Cullinan Oncology is expected to generate 2.48 times less return on investment than Dice Molecules. But when comparing it to its historical volatility, Cullinan Oncology LLC is 1.08 times less risky than Dice Molecules. It trades about 0.07 of its potential returns per unit of risk. Dice Molecules Holdings is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  2,746  in Dice Molecules Holdings on March 19, 2024 and sell it today you would earn a total of  1,951  from holding Dice Molecules Holdings or generate 71.05% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	30.97%
Values	Daily Returns

Cullinan Oncology LLC  vs.  Dice Molecules Holdings

Cullinan Oncology LLC

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cullinan Oncology LLC are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain technical and fundamental indicators, Cullinan Oncology displayed solid returns over the last few months and may actually be approaching a breakup point.

Dice Molecules Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dice Molecules Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Dice Molecules is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Cullinan Oncology and Dice Molecules

The main advantage of trading using opposite Cullinan Oncology and Dice Molecules positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Dice Molecules can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dice Molecules will offset losses from the drop in Dice Molecules' long position.

The idea behind Cullinan Oncology LLC and Dice Molecules Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.